Their data showed that DNA methylation and histone acetylation can regulate the activity of the SSTR2 promoter and demonstrated that promoter activity directly correlates with SSTR2 expression in breast cancer, pancreatic cancer, hepatic cancer, melanoma and retinoblastoma cell lines in an inverse fashion. Here, SSTR2 is linked to breast cancer.